Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 19

Results For "MEA"

1160 News Found

JHU signs MoU with Ajit Isaac Foundation to bring essential palliative care services to rural India’s terminally ill
Healthcare | November 22, 2024

JHU signs MoU with Ajit Isaac Foundation to bring essential palliative care services to rural India’s terminally ill

The collaboration offers opportunities for training, research fellowships, workshops and conferences at palliative care centers managed by Ajit Isaac Foundation


Emcure and MS Dhoni drive India’s fight against Anemia
Healthcare | November 21, 2024

Emcure and MS Dhoni drive India’s fight against Anemia

Emcure has launched an awareness campaign to help spread the word about male anemia


Blenrep shows overall survival benefit in DREAMM-7 phase III trial for relapsed/refractory multiple myeloma
Diagnostic Center | November 19, 2024

Blenrep shows overall survival benefit in DREAMM-7 phase III trial for relapsed/refractory multiple myeloma

Statistically significant and clinically meaningful reduction in the risk of death seen with Blenrep (belantamab mafodotin) plus bortezomib and dexamethasone (BorDex) versus daratumumab plus BorDex


Emcure Pharmaceuticals teams up with MS Dhoni to bat for stroke awareness
Healthcare | November 17, 2024

Emcure Pharmaceuticals teams up with MS Dhoni to bat for stroke awareness

Emcure and Dhoni, through a video, urge everyone to be aware about symptoms of stroke and educate at least one person for identification of stroke and spread its awareness


IOL Chemicals and Pharmaceuticals posts Q2 FY25 PT at Rs. 19 Cr
News | November 16, 2024

IOL Chemicals and Pharmaceuticals posts Q2 FY25 PT at Rs. 19 Cr

Total Income in Q2 FY25 stood at Rs. 532.18 crore


AbbVie provides update on Phase 2 results for Emraclidine in schizophrenia
News | November 14, 2024

AbbVie provides update on Phase 2 results for Emraclidine in schizophrenia

Emraclidine was well-tolerated with an adverse event profile consistent with Phase 1b trial


Akums Drugs and Pharmaceuticals posts Q2 FY25 adjusted PAT at Rs. 66.7 Cr
News | November 11, 2024

Akums Drugs and Pharmaceuticals posts Q2 FY25 adjusted PAT at Rs. 66.7 Cr

For Q2, Akums reported a consolidated total income of Rs. 1,046.6 crore


DuPont launches Tyvek to support sustainable healthcare packaging
Packaging | November 09, 2024

DuPont launches Tyvek to support sustainable healthcare packaging

Tyvek with Renewable Attribution is designed to help reduce the carbon footprint